PRMT1 and Miyoshi myopathy: To further evaluate the potential clinical value of PRMT1 in the treatment of MM, we selected the PRMT1-selective small-molecule inhibitor C7280948, which has been reported to suppress cell proliferation, migration, and invasion in colorectal cancer [26].